Y10S 977/803
Containing biological material in its interior
Y10S977/803 (Containing biological material in its interior) appears on 109 US grants and 39 published applications in this corpus.
Search patents in Y10S- Granted patents
- 109
- Published applications
- 39
- Assignees
- 66
- Inventors
- 185
- Latest grant
- 2 Jun 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 2 | 0 |
| 1997 | 2 | 0 |
| 1998 | 17 | 0 |
| 1999 | 19 | 0 |
| 2000 | 10 | 0 |
| 2001 | 11 | 3 |
| 2002 | 22 | 5 |
| 2003 | 6 | 11 |
| 2004 | 0 | 5 |
| 2005 | 1 | 4 |
| 2006 | 2 | 5 |
| 2007 | 3 | 1 |
| 2008 | 2 | 2 |
| 2009 | 2 | 1 |
| 2010 | 1 | 1 |
| 2011 | 3 | 0 |
| 2012 | 1 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 1 | 0 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Nanocaged enzymes with enhanced catalytic activity and increased stability2 Jun 2020US 10,669,534 B2Arizona Board of Regents on behalf of Arizona State University
- Methods and compositions for imaging17 Jan 2012US 8,097,283 B2Mount Sinai School of Medicine
- Pseudotyped retrovirus with modified ebola glycoprotein19 Jul 2011US 7,981,656 B2Centers for Disease Control and Prevention
- Eukaryotic layered vector initiation systems12 Jul 2011US 7,977,091 B2Novartis Vaccines and Diagnostics, Inc.
- Methods and compositions for imaging24 May 2011US 7,947,307 B2Mount Sinai School of Medicine of New York University
- Nanocaged Enzymes with Enhanced Catalytic Activity and Increased Stability18 Jan 2018US 2018/0016569 A1Arizona Board of Regents on behalf of Arizona State University
- Eukaryotic Layered Vector Initiation Systems8 Jul 2010US 2010/0173412 A1Novartis Vaccines and Diagnostics, Inc.
- High-Efficiency Fusogenic Vesicles, Methods of Producing Them, and Pharmaceutical Compositions Containing Them12 Nov 2009US 2009/0280163 A1Pevion Biotech Ltd.
- Hepatitis C virus asialoglycoproteins25 Dec 2008US 2008/0318275 A1
- Cationic liposomes containing immune response generating moieties20 Nov 2008US 2008/0286353 A1Lipoxen Technologies Limited
Most cited
By later US patents
- Eukaryotic layered vector initiation systems204US 5,814,482 A1998
- Virus vectors and methods of making and administering the same197US 7,172,893 B2The University of North Carolina at Chapel Hill · 2007
- Alphavirus vector constructs167US 5,843,723 AChiron Corporation · 1998
- Recombinant parvovirus vectors and method of making167US 6,491,907 B1The University of North Carolina at Chapel Hill · 2002
- Inducing cytotoxic T lymphocyte responses157US 5,928,647 ADana-Farber Cancer Institute, Inc. · 1999